Arbutus Biopharma ABUS
NASDAQ ABUS
$4.20 -0.01 (-0.24%)
At close: Oct 23, 2026 · 4:00 PM EDT

Arbutus Biopharma (ABUS) Sale and Maturity of Investments (2015 - 2026)

Updated

Analysis

Arbutus Biopharma (ABUS) Sale and Maturity of Investments (2015 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Arbutus Biopharma 830.06 Mn 457.04 Mn - 22.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 22.00 Mn
Mar 31, 2026 16.00 Mn
Dec 31, 2025 23.83 Mn
Sep 30, 2025 41.28 Mn
Jun 30, 2025 44.10 Mn
Mar 31, 2025 46.07 Mn
Dec 31, 2024 56.69 Mn
Sep 30, 2024 28.35 Mn
Jun 30, 2024 42.42 Mn
Mar 31, 2024 37.19 Mn
Dec 31, 2023 46.24 Mn
Sep 30, 2023 17.53 Mn
Jun 30, 2023 31.50 Mn
Mar 31, 2023 37.00 Mn
Dec 31, 2022 26.00 Mn
Sep 30, 2022 19.00 Mn
Jun 30, 2022 9.00 Mn
Mar 31, 2022 2.00 Mn
Dec 31, 2021 20.00 Mn
Sep 30, 2021 16.00 Mn
API Access

Arbutus Biopharma Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=ABUS&period=max&api_key=YOUR_API_KEY